Literature DB >> 22343198

Acute decompensated heart failure - treatments and challenges - .

Barry Greenberg1.   

Abstract

Acute decompensated heart failure (ADHF) is a major public health problem throughout the world and its importance is continuing to grow. This article reviews the epidemiology of ADHF and the profile of patients suffering from this condition. It describes factors used in assessing prognosis and presents treatment options. Although no currently available treatments have been shown to favorably affect long-term outcomes, there are a variety of strategies and approaches to management that are expected to reduce morbidity and mortality following discharge after ADHF hospitalization. In particular, the clinician is alerted to the need to identify factors that trigger decompensation as well as to optimize treatments for chronic heart failure. The importance of the transition from hospital to the outpatient setting is described. Particular attention should be focused on providing health education to the patient and their family at an appropriate level of medical literacy as well as ensuring early follow-up evaluation after hospital discharge.

Entities:  

Mesh:

Year:  2012        PMID: 22343198     DOI: 10.1253/circj.cj-12-0130

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  10 in total

Review 1.  [Acute heart failure].

Authors:  U Janssens
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-06-13       Impact factor: 0.840

2.  Nurse-Led Multidisciplinary Heart Failure Group Clinic Appointments: Methods, Materials, and Outcomes Used in the Clinical Trial.

Authors:  Carol E Smith; Ubolrat Piamjariyakul; Kathleen M Dalton; Christy Russell; Jo Wick; Edward F Ellerbeck
Journal:  J Cardiovasc Nurs       Date:  2015 Jul-Aug       Impact factor: 2.083

3.  Epidemiology, Risk Factors and Etiology of Altered Level of Consciousness Among Patients Attending the Emergency Department at a Tertiary Hospital in Mogadishu, Somalia.

Authors:  Hassan Adan Ali; Mohamed Farah Yusuf Mohamud
Journal:  Int J Gen Med       Date:  2022-05-30

4.  Nitroxyl (HNO): A novel approach for the acute treatment of heart failure.

Authors:  Hani N Sabbah; Carlo Gabriele Tocchetti; Mengjun Wang; Samantapudi Daya; Ramesh C Gupta; Richard S Tunin; Reza Mazhari; Eiki Takimoto; Nazareno Paolocci; Douglas Cowart; Wilson S Colucci; David A Kass
Journal:  Circ Heart Fail       Date:  2013-10-09       Impact factor: 8.790

Review 5.  Chemohypersensitivity and autonomic modulation of venous capacitance in the pathophysiology of acute decompensated heart failure.

Authors:  Amy E Burchell; Paul A Sobotka; Emma C Hart; Angus K Nightingale; Mark E Dunlap
Journal:  Curr Heart Fail Rep       Date:  2013-06

6.  Transient heart rate reduction improves acute decompensated heart failure-induced left ventricular and coronary dysfunction.

Authors:  Nicolas Peschanski; Najah Harouki; Matthieu Soulie; Marianne Lachaux; Lionel Nicol; Isabelle Remy-Jouet; Jean-Paul Henry; Anais Dumesnil; Sylvanie Renet; Françoise Fougerousse; Ebba Brakenhielm; Antoine Ouvrard-Pascaud; Christian Thuillez; Vincent Richard; Jérôme Roussel; Paul Mulder
Journal:  ESC Heart Fail       Date:  2021-01-20

7.  Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure.

Authors:  Abdurrahman Tasal; Mesut Demir; Mehmet Kanadasi; Ahmet Bacaksiz; Mehmet Akif Vatankulu; Durmus Yıldıray Sahin; Rabia Akıllı Eker; Abdi Bozkurt; Esmeray Acarturk
Journal:  Med Sci Monit       Date:  2014-02-19

8.  Impact of chronic kidney disease on the diuretic response of tolvaptan in acute decompensated heart failure.

Authors:  Shuntaro Ikeda; Kiyotaka Ohshima; Shigehiro Miyazaki; Hisaki Kadota; Hideaki Shimizu; Akiyoshi Ogimoto; Mareomi Hamada
Journal:  ESC Heart Fail       Date:  2017-07-14

9.  Intravenous Infusion of the Novel HNO Donor BMS-986231 Is Associated With Beneficial Inotropic, Lusitropic, and Vasodilatory Properties in 2 Canine Models of Heart Failure.

Authors:  J Craig Hartman; Carlos L Del Rio; John E Reardon; Kefei Zhang; Hani N Sabbah
Journal:  JACC Basic Transl Sci       Date:  2018-11-12

10.  A Phase 1 Randomized Study of Single Intravenous Infusions of the Novel Nitroxyl Donor BMS-986231 in Healthy Volunteers.

Authors:  Douglas Cowart; Robert P Venuti; Kim Lynch; Jeffrey T Guptill; Robert J Noveck; Shi Yin Foo
Journal:  J Clin Pharmacol       Date:  2019-01-31       Impact factor: 3.126

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.